We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Systec GmbH

Systec GmbH is a manufacturer of autoclaves (steam sterilizers), especially laboratory autoclaves, media preparators ... read more Featured Products: More products

Download Mobile App





Systec Launches New and Improved HX-150 Autoclave at MEDICA 2019

By LabMedica International staff writers
Posted on 18 Nov 2019
Print article
Illustration
Illustration
Systec GmbH (Nuremberg, Germany) launched the first product from its re-designed Systec H-Series: the new and improved Systec HX-150 autoclave at the MEDICA 2019 International Trade Fair on November 18-21 in Düsseldorf, Germany. In addition to the new generation of autoclaves, visitors at MEDICA 2019 got a closer look at several other Systec devices, including not only autoclaves, but also advanced media preparators and the Systec Mediafill dispensing and dosing system. Systec’s partner company Evidencia GmbH also introduced innovative concepts for qualifying and validating equipment and sterilization processes.

MEDICA is the world's largest medical trade fair for medical technology, electromedical equipment, laboratory equipment, diagnostics and pharmaceuticals. More than 5,000 exhibitors from 70 countries presented their newest products and ideas at MEDICA 2019 which drew 120,000 trade visitors from over 170 countries.

The Systec H-Series floor-standing autoclaves of the performance category HX can be used for all laboratory applications, even for sophisticated sterilization processes and are available in 16 different sizes with 65 to 1580 liters chamber volume. All additional optional accessories can be fitted to obtain validatable processes. In spite of the high loading capacity, these autoclaves are compact and have a comparatively low weight.

The Systec HX-150 autoclave is the world’s first device from the new, improved Systec H-Series – a new generation of autoclaves in a new design, with a completely overhauled interior, and a touchscreen control that has been newly developed from scratch. This combination guarantees more precise work, easier to maintain equipment, and up to 25% faster autoclaving processes. In addition, the new autoclaves come with an Ethernet port as standard and optional Wi-Fi hardware to optimise updating processes, remote maintenance, and remote control of the devices via a computer network. An integrated USB port allows the automated export of documentation data in CSV or PDF format. The volume of the extended internal memory also allows storage of up to 10 years of documentation data. This eliminates the need for separate programs for documentation and archiving that are the otherwise necessary. This integrated documentation function is also interesting from a regulatory point of view, because the new generation of the Systec H- Series automatically fulfils an essential point of the FDA guideline 21 CFR Part 11. Additional features of the series also serve to satisfy regulatory requirements from the pharmaceutical industry, such as automatically distributed, tamper-proof signatures for the PDF and CSV files that are generated, and the tracking of all actions, adjustments, and alerts using AuditTrail.

Related Links:
Systec GmbH

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Xylazine Immunoassay Test
Xylazine ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: AI analysis of DNA fragmentomes and protein biomarkers noninvasively detects ovarian cancer (Photo courtesy of Adobe Stock)

Blood-Based Machine Learning Assay Noninvasively Detects Ovarian Cancer

Ovarian cancer is one of the most common causes of cancer deaths among women and has a five-year survival rate of around 50%. The disease is particularly lethal because it often doesn't cause symptoms... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The groundbreaking treatment approach has shown promise in hard-to-treat cancers (Photo courtesy of 123RF)

Genetic Testing Combined With Personalized Drug Screening On Tumor Samples to Revolutionize Cancer Treatment

Cancer treatment typically adheres to a standard of care—established, statistically validated regimens that are effective for the majority of patients. However, the disease’s inherent variability means... Read more

Pathology

view channel
Image: The device can serve as a sample pretreatment tool for cytological diagnosis of malignant effusions (Photo courtesy of Microsystems & Nanoengineering: Zhu, Z., Ren, H., Wu, D. et al.)

Microfluidic Device for Cancer Detection Precisely Separates Tumor Entities

Tumor cell clusters are increasingly recognized as crucial in cancer pathophysiology, with growing evidence of their increased resistance to treatment and higher metastatic potential compared to single tumor cells.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.